Company Profile
Updated: 07-DEC-09Corneal Design
Private Company, Headquarters Location
18709 Mooney Dr., Gaithersburg, MD 20879, United States
USA (800)634-0785, (301)670-7076, USA (301)670-9450 fax,
Primary SIC: Ophthalmic Goods, Primary NAICS: Ophthalmic Goods Merchant Wholesalers
Description: Wholesale: Medical, Dental, and Optical Supplies
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
ClearKone by SynergEyes Awarded Most Innovative New Product of 2009.
Health & Medicine Week; 1/4/2010; 1006 words; ...advanced hybrid contact lens design for keratoconus patients...patent-pending contact lens design that provides superior visual...day comfort. This "hybrid" design incorporates the benefits of...vision correction short of a corneal transplant. Eye glasses cannot...
OPHTHALMIC SURGEONS EMPLOY CUTTING-EDGE TECHNOLOGY
US Fed News Service, Including US State News; 12/26/2009; 737 words; ...shorten recovery times for corneal transplantation. Members of...allows ophthalmic surgeons to design very specific interfaces between...team performed the first three corneal transplants using this technology...The normal recovery time for corneal transplantation patients is...
OPHTHALMIC SURGEONS EMPLOY CUTTING-EDGE TECHNOLOGY.
States News Service; 12/24/2009; 851 words; ...shorten recovery times for corneal transplantation. Members of...allows ophthalmic surgeons to design very specific interfaces between...team performed the first three corneal transplants using this technology...The normal recovery time for corneal transplantation patients is...
Research from University of London, Medical Department provide new insights into nucleic acids research.(Report)
Life Science Weekly; 12/22/2009; 1153 words; "Gene transfer to the corneal endothelium has potential in preventing corneal transplant rejection. In this study, we transfected mouse corneal endothelial cells (MCEC...peptides featured a tri-block design and mediated reporter gene...
ClearKone(TM) by SynergEyes(R) Awarded Most Innovative New Product of 2009.
PR Newswire; 12/21/2009; 933 words; ...advanced hybrid contact lens design for keratoconus patients...patent-pending contact lens design that provides superior visual...day comfort. This "hybrid" design incorporates the benefits of...vision correction short of a corneal transplant. Eye glasses cannot...
Recent News Articles
- International Stem Cell Corporation Reports Positive Pre-Clinical Trial Results From Human Corneal Epithelial Cells Trials Designed to Improve Laser Eye Surgery Outcomes.
Biotech Week - June 24, 2009 - EyeGate Pharma receives Orphan Drug Designation from FDA for treating corneal graft rejection.
Transplant News - February 01, 2009 - Lux Granted Fast Track Designation for LX201 for Corneal Transplant Rejection.
Business Wire - January 30, 2008 - LX201 (Lux Biosciences).(Orphan drug designations)(treatment for rejection in corneal transplantation)(Brief article)
Formulary - March 01, 2007
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning